IRIS
SCORSETTI, Marta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.230
AS - Asia 6.589
EU - Europa 2.961
SA - Sud America 2.058
AF - Africa 478
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 19
AN - Antartide 1
Totale 28.375
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.011
SG - Singapore 4.085
BR - Brasile 1.755
CN - Cina 1.258
FI - Finlandia 638
IE - Irlanda 538
VN - Vietnam 419
NG - Nigeria 362
DE - Germania 359
IT - Italia 325
FR - Francia 255
HK - Hong Kong 229
GB - Regno Unito 192
NL - Olanda 166
SE - Svezia 152
CA - Canada 126
IN - India 109
AR - Argentina 106
RU - Federazione Russa 81
TR - Turchia 77
BD - Bangladesh 69
EC - Ecuador 59
MX - Messico 51
ID - Indonesia 49
IL - Israele 48
CO - Colombia 41
IQ - Iraq 41
CL - Cile 36
ZA - Sudafrica 36
AU - Australia 34
BE - Belgio 33
UA - Ucraina 32
AT - Austria 30
PL - Polonia 30
PK - Pakistan 28
ES - Italia 24
UZ - Uzbekistan 24
CZ - Repubblica Ceca 22
JP - Giappone 21
VE - Venezuela 20
KE - Kenya 17
MA - Marocco 17
PY - Paraguay 17
SA - Arabia Saudita 15
JO - Giordania 14
LT - Lituania 14
OM - Oman 14
A2 - ???statistics.table.value.countryCode.A2??? 13
TN - Tunisia 13
EG - Egitto 12
KZ - Kazakistan 12
PE - Perù 12
RO - Romania 12
AE - Emirati Arabi Uniti 11
UY - Uruguay 11
GR - Grecia 10
AZ - Azerbaigian 9
NO - Norvegia 9
DZ - Algeria 8
HN - Honduras 8
NP - Nepal 8
IR - Iran 7
PA - Panama 7
DO - Repubblica Dominicana 6
AL - Albania 5
CH - Svizzera 5
MY - Malesia 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
EU - Europa 4
JM - Giamaica 4
KG - Kirghizistan 4
PS - Palestinian Territory 4
BB - Barbados 3
BG - Bulgaria 3
BH - Bahrain 3
BY - Bielorussia 3
CR - Costa Rica 3
DK - Danimarca 3
GT - Guatemala 3
HU - Ungheria 3
KR - Corea 3
LB - Libano 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
TZ - Tanzania 3
BW - Botswana 2
ET - Etiopia 2
GD - Grenada 2
GE - Georgia 2
HR - Croazia 2
KH - Cambogia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MD - Moldavia 2
NI - Nicaragua 2
RS - Serbia 2
SI - Slovenia 2
Totale 28.354
Salva come PNG Salva come JPEG
Città #
Wilmington 2.603
Chandler 2.172
Dallas 1.801
Singapore 1.317
San Mateo 1.014
The Dalles 995
Shanghai 763
Ann Arbor 720
Helsinki 636
Dublin 534
Leawood 456
Lawrence 438
Princeton 438
Boardman 402
Ashburn 394
Benin City 361
Beijing 270
Fairfield 261
New York 260
Woodbridge 251
Paris 232
Hong Kong 202
São Paulo 159
Ho Chi Minh City 152
Amsterdam 143
Milan 111
London 96
Seattle 94
Hanoi 80
Los Angeles 80
Santa Clara 74
Toronto 72
Norwalk 71
Rio de Janeiro 54
San Diego 52
Kocaeli 46
Belo Horizonte 45
Phoenix 43
Council Bluffs 35
Brussels 32
Porto Alegre 30
Curitiba 28
Munich 27
Naples 27
Brasília 26
Haiphong 25
Nuremberg 24
Falkenstein 23
Redwood City 23
Guarulhos 22
Mexico City 22
Brooklyn 21
Campinas 20
Guayaquil 20
Pune 20
Tashkent 20
Tokyo 20
Des Moines 19
Dhaka 19
Monmouth Junction 19
Montreal 19
Chennai 18
Johannesburg 18
Vienna 18
Baghdad 17
Fortaleza 17
Quito 17
Redmond 17
Salvador 17
San Francisco 17
Santo André 17
Warsaw 17
Columbus 16
Recife 15
Thái Bình 15
Amman 14
Brno 14
Da Nang 14
Nairobi 14
Osasco 14
Ribeirão Preto 14
Milwaukee 13
Ninh Bình 13
Boston 12
Nova Iguaçu 12
Stockholm 12
Atlanta 11
Goiânia 11
Maceió 11
Orem 11
Sorocaba 11
Bogotá 10
Buenos Aires 10
Buffalo 10
Duque de Caxias 10
Düsseldorf 10
Joinville 10
Manchester 10
Mauá 10
Poplar 10
Totale 18.960
Salva come PNG Salva come JPEG
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 609
11C Choline PET Guided Salvage Radiotherapy with Volumetric Modulation Arc Therapy and Hypofractionation for Recurrent Prostate Cancer after HIFU Failure: Preliminary Results of Tolerability and Acute Toxicity 546
A circulating miRNA signature to implement diagnostic imaging analysis in young early-stage breast cancer patients 115
Can advanced new radiation therapy technologies improve outcome of high grade glioma (HGG) patients? Analysis of 3D-conformal radiotherapy (3DCRT) versus volumetric-modulated arc therapy (VMAT) in patients treated with surgery, concomitant and adjuvant chemo-radiotherapy 112
"Early Clinical Assessment Of Feasibility And Safety In Flattering Filter Free (FFF) Based Stereotactic Body Radiotherapy (SBRT) Treatments" 108
Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases 108
Carbon-11-methionine PET-CT as an imaging biomarker in brain gliomas eligible for surgery 106
ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study (CROSS): Single Center Experience 104
"Reirradiation: hopes and concerns of the radiation oncologist" Reply 103
Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme 100
Accuracy evaluation of fusion of CT, MR, and SPECT images using commercially available software packages (SRS PLATO and IFS) 99
A Radiomic Approach to Predict Nodal and Distant Relapse in Patients Treated with Stereotactic Body Radiation Therapy for Early Stage NSCLC 99
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study 99
A broad scope knowledge based model for optimization of VMAT in esophageal cancer: validation and assessment of plan quality among different treatment centers. 97
A LARGE, MULTICENTER, RETROSPECTIVE STUDY ON EFFICACY AND SAFETY OF STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN OLIGOMETASTATIC OVARIAN CANCER (MITO RT1 STUDY) 96
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 96
Role of Surgical Resection in Patients with Single Large Brain Metastases: Feasibility, Morbidity, and Local Control Evaluation. 94
Assessment of prognostic factors in patients with metastatic epidural spinal cord compression (MESCC) from solid tumor after surgery plus radiotherapy: a single institution experience 94
Can HSRS on tumor bed replace WBRT in resected brain metastases? Results of a phase II study 93
SALVAGE RADIOTHERAPY WITH VOLUMETRIC MODULATION ARC THERAPY AND HYPOFRACTIONATION FOR RECURRENT PROSTATE CANCER AFTER HIFU FAILURE 92
A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer. 91
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 91
Accuracy evaluation of the optical surface monitoring system on EDGE linear accelerator in a phantom study. 90
Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation. 89
Survival outcome and prognostic factors after pulmonary metastasectomy in sarcoma patients 89
Adjuvant chemotherapy and hypofractionated VMAT treatment with SIB for early stage breast cancer: A prospective evaluation of acute toxicity and cosmetic results 89
High incidence of hypocalcemia and serum creatinine increase in patients with bone metastases treated with zoledronic acid 88
Can SBRT improve the prognosis of unresectable pancreatic cancer? Clinical results on 106 patients 88
Checkpoint inhibitors as treatment for malignant gliomas: "A long way to the top" 86
A Multi-Institutional Analysis on the Use of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Lymph Node Oligometastases in Prostate Cancer Patients 86
Adjuvant volumetric modulated arc therapy compared to 3D conformal radiation therapy for newly diagnosed soft tissue sarcoma of the extremities: outcome and toxicity evaluation 84
Cranio-spinal irradiation with volumetric modulated arc therapy: A multi-institutional treatment experience 84
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study 82
Addition of temozolomide to radiotherapy for treatment of newly diagnosed anaplastic gliomas 81
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach 81
Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis. 79
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 79
Phase II trial of stereotactic body radiation therapy for abdomino-pelvic lymph node oligometastases 79
Applying failure mode effects and criticality analysis in radiotherapy: Lessons learned and perspectives of enhancement 78
Adjuvant radiotherapy in endometrial cancer: Volumetric Modulated Intensity Arc Therapy vs 3DRT 78
Adjuvant radiotherapy for malignant pleural mesothelioma: Challenges and pitfalls 76
Hypofractionated stereotactic radiation therapy in skull base meningiomas 76
Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction 76
Diagnostic accuracy of C-11-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma 76
Developing an adolescent and young adult (AYA) cancer program in an Italian adult high-volume cancer center. 74
DCIS treated with breast conservative surgery and radiotherapy: a national multicentre experience 74
The use of radiation therapy for oligoprogressive/oligopersistent oncogene driven non small cell lung cancer: state of the art 73
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments. 72
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma 72
Liver Metastases-directed Therapy in the Management of Oligometastatic Breast Cancer 72
Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis. 71
Liver metastases from colorectal cancer: propensity score-based comparison of stereotactic body radiation therapy vs. microwave ablation 71
SBRT for unresectable locally advanced pancreatic cancer: clinical outcomes on 100 patients 71
Could single-high-dose radiotherapy be considered the new frontier of stereotactic ablative radiation therapy? 70
Hypofractionation in current clinical practice: a flash forward to the near future of radiation oncology? 70
STEREOTACTIC BODY RADIATION THERAPY AS LOCAL TREATMENT FOR OLIGOMETASTASES FROM PROSTATE CANCER: EFFICACY AND IMPACT ON SYSTEMIC TREATMENT 70
Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma. 70
Adjuvant chemotherapy and hypofractionated VMAT treatment with SIB for early stage breast cancer 69
Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study. 69
Early clinical experience with volumetric modulated arc therapy in head and neck cancer patients 68
Plan robustness in field junction region from arcs with different patient orientation in total marrow irradiation with VMAT. 68
Intracranial Meningiomas: A Systematic Analysis of Prognostic Factors for Recurrence in a Large Single Institution Surgical Series 68
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation 67
Applying Lean-Six-Sigma Methodology in radiotherapy: Lessons learned by the breast daily repositioning case. 67
HIGH-GRADE GLIOMAS AND IMMUNOTHERAPEUTIC EARLY PHASE CLINICAL TRIALS: A SINGLE-CENTER EXPERIENCE 67
Organs at risk in lung SBRT 66
Stereotactic radiotherapy with linear accelerators. Dosage considerations on collimators and photon beam energy 66
Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma 66
High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low-Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients. 66
The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT) 66
Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large series 66
SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience. 66
A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group 65
Acute Toxicity and Quality of Life in a Post-Prostatectomy Ablative Radiation Therapy (POPART) Multicentric Trial 65
Long-Term Follow-Up of Patients with Metastatic Epidural Spinal Cord Compression from Solid Tumors Submitted for Surgery Followed by Radiation Therapy 65
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study. 65
Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer Report of feasibility and acute toxicity 64
Can thoracic nodes oligometastases be safely treated with image guided hypofractionated radiation therapy? 64
Role of C-11-choline PET/CT in radiation therapy planning of patients with prostate cancer 64
Dosimetric evaluation of different radiotherapy modalities and calculations for soft tissue sarcoma 64
Randomized phase II study of hypofractionated WBI versus APBI using VMAT: early toxicity results 64
High-grade gliomas (HGGs) and immunotherapeutic early-phase clinical trials (ieCTs): A single-center experience 64
Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography 64
Percutaneous Vertebral Augmentation in Metastatic Disease: State of the Art 64
Phase II study of hypofractionated radiation therapy in elderly patients with newly diagnosed glioblastoma with poor prognosis 64
Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective 64
Discrepancies between UICC and AJCC TNM classifications for oral cavity tumors in the 8th editions and following versions 63
Feasibility of stereotactic body radiation therapy with volumetric modulated arc therapy and high intensity photon beams for hepatocellular carcinoma patients. 63
Critical Appraisal of the Risk of Secondary Cancer Induction From Breast Radiation Therapy With Volumetric Modulated Arc Therapy Relative to 3D Conformal Therapy. 63
Stereotactic/hypofractionated body radiation therapy as an effective treatment for lymph node metastases from colorectal cancer: an institutional retrospective analysis. 63
FIVE FRACTIONS LINAC BASED SBRT FOR LOW - INTERMEDIATE RISK PROSTATE CANCER: PRELIMINARY REPORT OF A PHASE II STUDY WITH FLATTENING FILTER FREE DELIVERY AND SPACE OAR 63
SBRT Dose Escalation Phase II Study for Liver Metastases Using Volumetric Modulated Arc Therapy (VMAT-RapidArc) 63
Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in a observational study 63
Survival Outcomes in Malignant Pleural Mesothelioma Patients Fit for Surgery According to Type of Procedure and Completeness of Resection 63
The 70-year-old newly diagnosed glioblastoma patients are older than the 65-year-old? Outcome evaluation of the two categories in a matched case control study with propensity score balancing 63
Semiautomatic method to identify the best phase for gated RT in lung region by 4D-PET/CT acquisitions 62
Stereotactic body radiation therapy for abdominal targets using volumetric intensity modulated arc therapy with RapidArc: Feasibility and clinical preliminary results 62
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study. 62
Outcome evaluation of patients with newly diagnosed anaplastic gliomas treated in a single institution 62
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intent. 62
Totale 8.678
Salva come PNG Salva come JPEG
Categoria #
all - tutte 221.473
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 221.473
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.482 0 0 0 0 0 1.475 604 382 992 521 15 493
2021/20222.197 98 21 31 545 13 10 87 367 195 236 513 81
2022/20236.230 950 184 550 711 552 514 9 520 1.176 533 461 70
2023/20243.204 206 383 736 116 94 318 131 140 134 60 357 529
2024/20255.284 107 154 91 67 78 576 337 583 786 1.304 573 628
2025/20267.050 2.082 965 1.810 1.704 420 69 0 0 0 0 0 0
Totale 28.719